We recently isolated PsADl cDNA from pea (Pisum sativum L. cv. Alaska) seedlings, whose mRNA abundantly accumulated in dormant axillary buds and disappeared after decapitation [Madoka and Mori (2000) Plant Cell Physiol. 41: 274]. To further elucidate the function of PsADl, we investigated the temporal and spatial distribution patterns of PsADl protein using Western blot and immunocytochemical analyses. Western blot analyses showed that accumulation patterns of PsADl protein in axillary buds after decapitation and in response to IAA and 6-benzyladenine were the same as those of PsADl mRNA. Immunocytochemical analyses showed that (1) PsADl proteins were localized in the procambia, leaf primordia, apical meristem, and secondary axillary buds in the dormant axillary bud, and this distribution was the same as that of PsADl mRNA, (2) PsADl proteins acropetally disappeared after decapitation, and (3) the growth of axillary buds occurred in the same manner. These acropetal changes occur in a manner similar to the way in which the procambium differentiates into vascular tissue. These results suggest that PsADl plays some role in the inhibition of growth and differentiation, or in the maintenance of the dormant state in axillary buds.
al. 1991) and ethylene (Burg and Burg 1968) , which are thought to inhibit the growth of axillary buds, are involved in the regulation of apical dominance. Although the role of plant hormones in apical dominance has been investigated, little is known about the molecular mechanism of dormancy in axillary buds.
Recently, investigations have been carried out to elucidate the molecular mechanism of apical dominance. One approach has been to analyze the regulation of the cell cycle, because the cell cycle in dormant axillary buds is arrested in the intact plant and starts after decapitation. Devitt and Stafstrom (1995) reported that dormant axillary buds contain Gl and G2 nuclei (at about a 3 : 1 ratio) and cells are arrested at three points in the cell cycle: in the mid-Gl stage, at the Gl/S boundary, and near the S/G2 boundary.
We have isolated cDNAs of proliferating cell nuclear antigen (PCNA), cyclinD, cyclinB, histone H4, and cdc2 from peas and have also analyzed cell cycle regulation in axillary buds (Shimizu and Mori 1998a) . Based on the mRNA accumulation patterns of these genes, we found that most cells in dormant axillary buds are arrested at the Gl phase in the cell cycle. Furthermore, we investigated the interactions between cell cycle regulatory proteins using specific antibodies against each regulatory protein. As a result, we found that the PCNA/Pissa; CycD3; 1 complex is formed in dormant axillary buds when the cells are arrested at the Gl phase and that the complex is dissociated after decapitation (Shimizu and Mori 1998b) .
Another approach has been to characterize some genes whose expression patterns changed in axillary buds after decapitation. Stafstrom's group characterized the expression patterns of genes of three cDNA clones in axillary buds. One of these clones, pGB8, encoded ribosomal protein L27, whose mRNA dramatically increased after decapitation (Stafstrom and Sussex 1992) . The other two clones are PsDRMl and PsDRM2, whose mRNAs accumulated in dormant axillary buds and rapidly decreased after decapitation (Stafstrom et al. 1998) . The deduced amino acid sequence of PsDRMl is similar to that of an auxin-repressed strawberry clone, ASAR5 (Reddy and Poovaiah 1990) . PsDRM2 encoded a putative glycine-rich protein that is similar to the alfalfa CORA protein, whose mRNA is induced by cold temperature and drought stress (Laberge et al. 1993 ) and the alfalfa GRPA protein, whose mRNA is induced by ABA and drought stress (Luo et al. 1991) . Although the mRNA expression patterns of PsDRMl and PsDRM2 genes were investigated, the functions of both genes are unknown.
We also isolated two cDNA clones encoding PsADl and PsAD2, which are different from PsDRMl and PsDRM2, from a cDNA library of dormant axillary buds using the differential display method (Madoka and Mori 2000) . The accumulation patterns of these mRNAs were investigated in axillary buds and in various growing and nongrowing tissues. We found that PsADl mRNA mainly accumulated in dormant axillary buds and that its amount rapidly decreased after decapitation of the terminal bud. In situ hybridization analyses indicated that PsADl mRNA was localized in the apical meristem, procambia, leaf primordia, and secondary axillary buds in dormant axillary buds that were competent to grow out but whose growth was temporarily suspended. These results suggested that the expression of the PsADl gene is closely associated with the dormancy of axillary buds. PsAD2 mRNA, on the other hand, accumulated in dormant axillary buds, roots, mature leaflets, and elongated stems, suggesting that PsAD2 is involved in not only the dormancy of axillary buds but also the non-growing state in various tissues.
The deduced amino acid sequence of PsADl consisted of 87 amino acids with a predicted molecular mass of 7,189 Da, and 45 (51.7%) of the residues were glycine. That is, PsADl was a small and glycine-rich protein and is different from PsDRM2, which is also a glycine-rich protein, since not only their sequences but also their mRNA expression patterns are different: PsDRM2 mRNA accumulated preferentially in dormant buds but was also present in growing buds (Stafstrom et al. 1998) .
To elucidate the function of PsADl protein in dormant axillary buds, we prepared an anti-PsADl antibody and investigated the accumulation and distribution patterns of PsADl protein by Western blot and immunocytochemical analyses.
Materials and Methods
Plant materials-Pea (Pisum sativum L. cv. Alaska) seeds were soaked in running tap water for 24 h and sown in trays of rockwool. Plants were grown at 25 °C in the dark for 3 d and then in a 16-hour light/8-hour dark photoperiod for 4 d.
Plants were decapitated 1 cm above the second node to stimulate the growth of dormant axillary buds. The node of intact 7-d-old pea plants contains four dormant axillary buds. All four buds at the second node were collected at several time points during the first 24 h after decapitation. The main and accessory buds were collected daily for a period of 5 d after decapitation. At 5 d after decapitation, the main bud was removed, and this stimulated the accessory bud to resume growing. The accessory bud was collected 1 d after removal of the main bud.
Terminal buds and roots were collected from 7-d-old seedlings. Young (expanding) and mature (expanded) leaflets were collected from the fifth and third nodes of 7-d-old plants, respectively. Elongating and elongated stems were collected from the fourth and second internodes of 10-d-old seedlings.
Hormone treatments-Seven-day-old pea seedlings were decapitated 1 cm above the second node, and lanolin paste with 1 % (w/w) indole-3-acetic acid (IAA) or without (mock IAA treatment) was immediately applied onto their stumps. Ten jul of 50% (v/v) ethanol and 10% (w/v) polyethylene glycol 1500 solution with 1.5 mM 6-benzyladenine (BA) or without BA (mock BA treatment) was applied directly onto the axillary buds on intact plants. Axillary buds at the second node were collected at 0, 16 and 24 h after the treatment of each hormone.
Preparation of an antibody and Western blot analysis-For preparation of an anti-PsADl antibody, a peptide based on the deduced amino acid residues 59 to 87 of PsADl (H 2 N-CGGSYI-SRGAFESNPQGYFSDLHAADKGSK-COOH) was synthesized. The cysteine residue at the amino terminus was added for conjugation of carrier proteins. One mg of the peptide was coupled to 1 mg of bovine serum albumin with w-maleimidobenzoyl-N-hydrosuccinimide ester (Pierce, Rockford, IL, U.S.A.). The resultant peptide was injected into rabbits. The antibody was purified and its specificity was determined as described by Shimizu and Mori (1998b) .
For Western blot analyses, axillary buds were directly ground with 2 x SDS sample buffer (20 mM Tris-HCl [pH 6.8], 40% glycerol, 2% SDS, 2% /?-mercaptoethanol and Bromophenol Blue), and insoluble materials were removed by centrifugation. The supernatant was heated at 95 °C for 2 min. One fifth of the protein extracted from one bud was loaded onto each lane; or proteins from various tissues were extracted by grinding with aluminum oxide in phosphate-buffered saline containing 0.2% yff-mercaptoethanol, 0.1% Triton-X 100 and 1 mM phenylmethylsulfonyl fluoride and insoluble materials were removed by centrifugation. Protein concentrations were determined with the DC Protein Assay (Bio-Rad). Ten or thirty jug of protein was loaded onto each lane. Proteins were separated by SDS-PAGE on a 15% polyacrylamide gel in 0.1 M Tris-0.1 M Tricine buffer containing 0.1% SDS. Molecular masses were estimated using Peptide Molecular Weight Marker Daiichi (Daiichi Pure Chemicals, Tokyo, Japan). After SDS-PAGE, polypeptides were blotted onto nitrocellulose membranes (BA-S85, Schleicher & Schuell, Dassel, Germany). The affinity-purified antibody raised against PsADl protein was used at a concentration of 1 jug IgGml" 1 , and immunoreactive polypeptides were visualized by 5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium as substrates for alkaline phosphatase.
Isolation of PsADl protein-Protein from 200 dormant axillary buds was extracted by grinding with aluminum oxide in phosphate-buffered saline containing 0.2% yS-mercaptoethanol, 0.1% Triton-XlOO and 1 mM phenylmethylsulfonyl fluoride. Insoluble materials were removed by centrifugation. The soluble fraction was heated at 80°C for 10 min, and then denatured insoluble proteins were removed by centrifugation again and the soluble fraction was further purified.
The soluble fraction was loaded onto an SP Sepharose column (Amersham Pharmacia Biotech) preequilibrated with buffer A (50 mM potassium phosphate buffer, pH 6.8). After unbound materials had been washed from the column with buffer A, PsADl protein was eluted with a step gradient of buffer A containing 0.1 M, 0.2 M, 0.3 M, and 0.4 M NaCl, respectively. PsADl fractions were detected by Western blot analyses with an anti-PsADl antibody. The following steps were performed by chromatography on a Smart system (Amersham Pharmacia Biotech). The obtained PsADl fractions were separated by a gel filtration column, Superdex peptide PC 3.2/30, with 0.1 M ammonium acetate buffer (pH5.0) at a flow rate of 100^1 m i n 1 . PsADl fractions were collected, lyophilized, and then dissolved in O.l°/o trifluoroacetic acid. Subsequently, the obtained sample was fractionated on a reversed phase chromatography column, fiRPC C2/C18 SC2.1/10, with a 0 to 40% gradient of acetonitrile in O.l°7o trifluoroacetic acid for 120min at a flow rate of 60//1 min"
1 . Finally, two purified fractions were obtained. N-terminal sequence analyses were performed on a gas-phase sequencer (model 476A, PE Applied Biosystems).
In vitro transcription/translation and immunoprecipitation -A cDNA fragment corresponding to nucleotides 11 to 404 of PsADl cDNA, encoding the full-length protein, was cloned into the pBluescript SK+ vector (Stratagene). In vitro transcription/translation was performed in a TNT T7 Coupled Reticulocyte Lysate System (Promega Biotec, Madison, WI) in the presence of 35 S-methionine/cysteine according to the manufacturer's protocol. Translation products were immunoprecipitated with an anti-PsADl antibody for 1 h and subsequently with Protein ASepharose (Amersham Pharmacia Biotech) for 1 h. Control immunoprecipitations were carried out with preimmune serum or anti-PsADl antibody in the presence of a synthesized PsADl peptide as a competitor. Sepharose beads were then pelleted and washed, and immunocomplexes were eluted with 1 x SDS sample buffer and analyzed by SDS-PAGE. Dried gels were placed on an Imaging Plate, and the radiographic images were analyzed using a Bioimaging Analyzer BAS2000 (Fuji Photofilm. Co., Ltd., Tokyo, Japan).
Immunocytochemistry-Sections were prepared as described by Kouchi and Hata (1993) except that they were mounted on 3-aminopropyltriethoxy silane-coated slides (Matsunami Glass Ind., Ltd., Japan). Sections were blocked in 3% skim milk-0.05% Tween 20 in TBS (50 mM Tris-HCl [pH 8.0], 150 mM NaCl) for 30 min at room temperature, incubated with an anti-PsADl antibody (1 /ug IgG ml" 1 ), washed three times with 0.05% Tween 20 in TBS, and then reacted with alkaline phosphatase-conjugated goat anti-rabbit IgG (Cappel, Durham, NC, U.S.A.). Signals were detected by the nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate staining method. A parallel control with preimmune serum was performed. Sharman staining was performed as described by Sharman (1943) .
Results

N-terminal amino acid sequence of
PsADl-An antibody against a synthesized peptide of PsADl was prepared. Western blot analyses of extracts from dormant axillary buds using the anti-PsADl antibody detected two polypeptides. The apparent molecular masses of PsADl protein on an SDS-PAGE gel (8.2 and 8.9 kDa) were slight ly larger than the molecular mass predicted from the PsADl cDNA nucleotide sequence (7,189 Da). The two PsADl polypeptides were purified for further characterization. Since the deduced amino acid sequence of PsADl indicated that the PsADl protein was a small peptide with a basic pi (10.3), firstly, extracts of dormant axillary buds were heated at 80°C for 10 min, and denatured insoluble proteins were removed by centrifugation. The soluble fraction was then loaded onto an SP Sepharose column. The fractions in which PsADl was detected by the antibody were eluted with 0.3 M NaCl. After gel filtration, the 8.2-and 8.9-kDa peptides were separated by reversed phase column chromatography, eluting at 12.7% and 13.1% acetonitrile, respectively. The N-terminal amino acid sequences of the two peptides were GGKGGSGGGAKGGGGGGG-AKGGGGGGGAKGGSGGGAKGGG (corresponding to amino acids 2 to 41 of PsADl) and GGKGGSGGGAK-GGGGGGGAKGGGGGGGAKGGSGGG (corresponding to amino acids 2 to 36), respectively (Madoka and Mori 2000) .
Characterization of the in vitro translation product of PsADl-In vitro translation products derived from PsADl cDNA were immunoprecipitated by the anti-PsADl antibody (Fig. 1A, upper panel, lane 8 ) and were also detected by Western blot analysis (Fig. 1A, lower panel, lanes 5 and  8) . This immunoprecipitation did not occur with preimmune serum or with the anti-PsADl antibody in the presence of the synthesized PsADl peptide (Fig. 1A , upper panel, lanes 7 and 9, respectively).
The molecular mass of in vitro translation products (Fig. 1A , upper panel, lanes 3, 5, and 8) was 8.9 kDa and was coincident with that of authentic PsADl proteins (Fig. 1A, lower panel, lane 1) although PsADl in the total in vitro translation products (Fig. 1A, upper panel, lane 3) seemed to be slightly smaller than other PsADl proteins (Fig. 1A , upper panel, lanes 5 and 8) due to the large amount of endogenous globin protein in the reticulocyte lysate. The in vitro translation products of PsADl protein remained soluble after heat treatment (Fig. 1A , upper panel, lane 5), which is a characteristic of authentic PsADl protein extracted from dormant axillary buds.
On the other hand, larger polypeptides (8.9 kDa) detected in extracts from dormant axillary buds decreased in size to 8.2-kDa polypeptides after incubation at room temperature for 1 h (Fig. IB, lower panel, lane 6 ), whereas they did not vary in the case of extracts containing SDS (Fig. IB, lower panel, lanes 1 and 7) . Furthermore, in vitro translation products (8.9 kDa) (Fig. IB, upper panel, lane  3 ) also decreased in size to 8.2-kDa polypeptides after incubation at room temperature for 1 h in the presence of extracts from dormant axillary buds (Fig. IB, upper and lower panels, lanes 4 and 5), whereas they did not vary in the presence of extracts containing SDS (Fig. IB, upper and lower panels, lane 2).
Accumulation pattern of PsADl protein- Figure 2B shows that the accumulation levels of both PsADl polypeptides were high in dormant axillary buds (at 0 h) and began to decrease 8 h after decapitation, although the accumulation levels and the pattern of total protein did not change ( Fig.2A) . The rate of decrease in PsADl protein was slightly slower than that in PsADl mRNA (Madoka and Mori 2000) .
We further investigated changes in the level of PsADl protein in the main and accessory buds during the growth-dormancy cycles (Fig. 2C) . By 2 d after decapitation, PsADl protein was no longer detected in the main bud. In the accessory buds, although PsADl protein was not detected until 3 d after decapitation, the level of PsADl began to increase from 4 d after decapitation when the accessory buds ceased growing and became dormant again (at 4, 5 d after decapitation) due to the growth of the main bud. When the accessory buds resumed growing after removal of the main bud at 5 d, the level of PsADl protein rapidly decreased 1 d later (6 d after decapitation).
We also investigated the accumulation of PsADl proteins in various tissues. PsADl proteins specifically accumulated in dormant axillary buds (Fig. 2D, lanes 1 and 2) . In other tissues, they were not detected (Fig. 2D, lanes Effects of IAA and 6-benzyladenine (BA) on the accumulation of PsADl-Application of IAA and BA to seedlings resulted in expression patterns of PsADl mRNA that were consistent with the conventional physiological data of apical dominance (Madoka and Mori 2000) . Therefore, in the present study, we investigated the effects of IAA and BA on the accumulation level of PsADl protein (Fig. 3) . When IAA was applied to the decapitated stumps of seedlings, the level of PsADl protein was maintained in axillary buds. Mock IAA treatment allowed the growth of axillary buds, and the level of PsADl protein decreased. On the other hand, the level of PsADl protein decreased in axillary buds to which BA was directly applied. Mock BA treatment did not promote the growth of axillary buds, and the level of PsADl protein was maintained.
Distribution of PsADl protein in dormant axillary buds-Cells in dormant axillary buds, especially the apical meristem, leaf primordia, procambia, secondary axillary buds, and procambia in leaf primordia stained dark orange with Sharman staining (Fig.4A, C, E) , indicating that these cells have the potential to actively divide (Sharman 1943) . Longitudinal and serial transverse sections of dormant axillary buds showed that PsADl protein was localized in each of these regions: in the apical meristem, leaf primordia, procambia (Fig.4B , D, 4F-6), in secondary axillary buds (Fig. 4F-3) , and in procambia in leaf primordia ( Fig. 4F -2-F-5). Staining with a preimmune serum did not give any signals (data not shown).
Temporal changes in the distribution of PsADl in axillary buds after decapitation-PsADl protein, which was clearly visible in leaf primordia just before decapitation (Fig. 5A ), began to disappear at 12 h after decapitation (Fig. 5B) . At 16 h to 18 h after decapitation, PsADl protein had disappeared in procambia but remained in the apical meristem. The stem and leaf primordia of axillary buds began to elongate (Fig. 5C, D decapitation (Fig. 5E, F) . Axillary buds elongated to about two times their original length 24 h after decapitation. That is, PsADl proteins disappeared consecutively from the base of the axillary bud toward the apical meristem, and the growth of the axillary bud occurred in the same manner.
Discussion
Two polypeptides (8.9 and 8.2 kDa) were detected in dormant axillary buds by Western blot analyses. The fact that the two polypeptides have the same N-terminal amino acid sequences and the finding that the 8.9-kDa polypeptides (the in vitro translation product and the protein ex- tracted from dormant axillary buds) decreased in size to 8.2-kDa polypeptides after incubation at room temperature without SDS (Fig. 1) suggest that the two polypeptides are the same gene products. Moreover, a Southern blot analysis of pea genomic DNA suggested that PsADl may be a single copy gene in the haploid genome (unpublished data). Based on these results, the 8.2-kDa polypeptide was probably derived from the 8.9-kDa polypeptide, probably through digestion at the carboxyl terminus by a protease in axillary buds. Additionally, the molecular mass of in vitro translation products was coincident with that of the authentic 8.9-kDa peptide in dormant axillary buds, suggesting that PsADl protein did not receive any post-translational processing or modification such as glycosylation or phosphorylation. Although PsADl is a basic protein like histone and protamine, it was probably localized in the cytosol, not in the nucleus, judging from the immunocytochemical analyses (unpublished data). This implies that it did not interact with DNA as do histone and protamine, or with RNA as do glycine-rich RNA-binding proteins (Alba et al. 1994 , Hirose et al. 1993 , Heintzen et al. 1994 . Furthermore, in a preliminary experiment, PsADl protein was not found in the poly some fraction, suggesting that it did not interact with RNA in the cytosol. Thus, it is still unknown what molecules PsADl proteins interact with.
The temporal accumulation pattern of PsADl protein in axillary buds after decapitation (Fig. 2) and the accumulation patterns in response to IAA and BA in axillary buds (Fig. 3) were the same as those of PsADl mRNA, suggesting that the expression of PsADl is transcriptionally regulated. However, the rate of decrease in PsADl protein was slower than that in PsADl mRNA after decapitation or in response to hormones (Madoka and Mori 2000) . For instance, PsADl mRNA was hardly detected at 14 h after decapitation, whereas PsADl protein was detected even at 24 h after decapitation, although the accumulation level was low. This difference is thought to be due to the slow turnover rate of PsADl protein. These results imply that PsADl is not an up-stream signal transduction factor that acts in response to the stimulus of decapitation. On the other hand, considering from the standpoint of the release of apical dominance, the post-translational regulation, especially the degradation of PsADl protein, is thought to play an important role in the release of inhibition of the growth of axillary buds.
Immunocytochemical analyses illustrated that PsADl proteins were localized in the procambia, leaf primordia, apical meristem and secondary axillary buds in dormant axillary buds (Fig. 4) . In each of these tissues, the cells were competent to grow but had temporarily stopped growing. Furthermore, the stained sections in Figure 5 indicate that, after decapitation, PsADl proteins acropetally disappeared, i.e., they disappeared consecutively from the base of the axillary bud toward the apical meristem, and that the growth of axillary buds occurred in the same manner. Differentiation of the procambium to the vascular tissue occurs in a similar acropetal manner. These results suggest that PsADl may play some role in the inhibition of growth and differentiation, or in the maintenance of the dormant state in axillary buds.
On the other hand, in situ hybridization analyses have demonstrated that PCNA mRNA appears in all parts of the axillary buds after decapitation (Shimizu and Mori 1998a) . That is, an acropetal gradient in the expression of PCNA was not detected. Based on these results, Shimizu and Mori reported that growth signals may diffuse or be transported rapidly to all cells of the axillary buds. Similarly, Stafstrom and Sussex (1992) suggested that pGB8, a ribosomal protein gene, was expressed in all parts of the axillary buds after decapitation. Taken together, these results suggest that the expressions of PsADl and PCNA resulting from the stimulus of decapitation are regulated by different pathways.
This study has shown that PsADl protein may be involved in the dormancy of axillary buds. However, the function of PsADl is still unknown. Analysis of transgenic plants manipulated with the PsADl gene and identification of protein factors that PsADl proteins interact with may help to reveal its function. Such studies should also help to clarify the molecular mechanism of dormancy of axillary buds.
